Zoetis (NYSE:ZTS) Stock Price Up 0.3%

Shares of Zoetis Inc. (NYSE:ZTS - Get Free Report) rose 0.3% on Tuesday . The stock traded as high as $162.13 and last traded at $160.19. Approximately 853,972 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 3,112,518 shares. The stock had previously closed at $159.70.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ZTS. Piper Sandler reiterated an "overweight" rating and set a $195.00 price target (down from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. Barclays decreased their target price on shares of Zoetis from $260.00 to $230.00 and set an "overweight" rating for the company in a research report on Tuesday, April 23rd. The Goldman Sachs Group raised their price target on shares of Zoetis from $190.00 to $226.00 and gave the company a "buy" rating in a report on Wednesday, January 17th. StockNews.com downgraded shares of Zoetis from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, February 20th. Finally, Stifel Nicolaus decreased their price target on Zoetis from $195.00 to $180.00 and set a "buy" rating for the company in a research note on Tuesday. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Zoetis has an average rating of "Buy" and a consensus target price of $216.13.

Zoetis Trading Down 0.3 %

The company's 50 day moving average is $170.66 and its 200 day moving average is $179.12. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.00 and a current ratio of 3.36. The stock has a market capitalization of $72.80 billion, a price-to-earnings ratio of 31.39, a PEG ratio of 2.42 and a beta of 0.85.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $1.24 EPS for the quarter, missing analysts' consensus estimates of $1.32 by ($0.08). Zoetis had a return on equity of 51.25% and a net margin of 27.43%. The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the business posted $1.15 EPS. Zoetis's revenue was up 8.5% compared to the same quarter last year. On average, research analysts forecast that Zoetis Inc. will post 5.79 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Thursday, April 18th. Zoetis's dividend payout ratio (DPR) is presently 34.12%.

Insiders Place Their Bets

In related news, EVP Roxanne Lagano sold 363 shares of Zoetis stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $197.74, for a total transaction of $71,779.62. Following the completion of the transaction, the executive vice president now directly owns 20,417 shares of the company's stock, valued at approximately $4,037,257.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 2,209 shares of company stock worth $371,293 over the last quarter. Company insiders own 0.16% of the company's stock.

Hedge Funds Weigh In On Zoetis

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Brookstone Capital Management increased its holdings in shares of Zoetis by 144.1% in the third quarter. Brookstone Capital Management now owns 13,030 shares of the company's stock valued at $2,190,000 after purchasing an additional 7,692 shares in the last quarter. PDS Planning Inc lifted its stake in shares of Zoetis by 3.6% during the third quarter. PDS Planning Inc now owns 2,291 shares of the company's stock valued at $399,000 after acquiring an additional 80 shares during the period. Commonwealth Equity Services LLC boosted its holdings in Zoetis by 3.4% in the third quarter. Commonwealth Equity Services LLC now owns 177,180 shares of the company's stock valued at $30,826,000 after acquiring an additional 5,764 shares during the last quarter. Vicus Capital acquired a new stake in Zoetis in the third quarter worth about $309,000. Finally, Robeco Institutional Asset Management B.V. raised its holdings in Zoetis by 0.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 666,276 shares of the company's stock worth $115,919,000 after purchasing an additional 5,999 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.